HOME
CAREERS
CONTACT US
KOREAN
ENGLISH
KR
EN
Toggle navigation
COMPANY
ABOUT US
KEY MEMBERS
HISTORY
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
SCIENCE
NT-I7
NeoBase
NT2020
NT3020
NT4010
NT5010
PIPELINE
Clinical
R&D
COLLABORATION
INVESTORS
NOTICE
PRESENTATION
GENERAL MEETING
OF STOCKHOLDERS
INDEPENDENT
AUDITOR'S REPORT
CONTACT IR
MEDIA
NEWS
VIDEO SOURCE
ESG
OVERVIEW
ENVIRONMENTAL
SOCIAL
GOVERNANCE
NEWS
HOME
MEDIA
NEWS
NEWS
All
Press Release
News Update
Quarterly update
Total
15
15
News Update
NeoImmuneTech Files International Patent Application for 'Multispecific Antibody Platform Technology'
2024-07-04
14
News Update
NeoImmuneTech’s Polish Subsidiary Obtains SME status
2024-05-30
13
News Update
Duke University Receives $6 Million contract from National Institutes of Health to Study NeoImmuneTech's NT-I7 in Treating Acute Radiation Syndrome
2024-05-13
12
News Update
Phase II Study Expansion Investigating NeoimmuneTech’s NT-I7 in Head and Neck Cancer
2024-01-29
11
News Update
NeoImmuneTech and NIAID Embark on a Collaborative Study to Explore New Treatment for Acute Radiation Syndrome (ARS)
2023-06-20
10
News Update
First Patient Dosed in Phase II Study of NeoImmuneTech’s NT-I7 plus Pembrolizumab in Recurrent Glioblastoma
2023-02-07
9
News Update
Pharmaphorum highlights NeoImmuneTech
2022-12-19
8
News Update
NeoImmuneTech to Present at 2023 Biotech Showcase
2022-12-15
7
News Update
NeoImmuneTech Joins the United Nations Global Compact
2022-10-11
6
News Update
NeoImmuneTech to Present at Cytokine-Based Drug Development Summit
2022-07-26
1
2
Search